#personalized-medicine
Liver Disease Diagnostics Market Insights Report 2026-2032 | Expansion of Fibrosis and Cirrhosis Screening Programs Propels Use of Imaging and Blood-Based Diagnostic Platforms
The market presents opportunities driven by rising liver disease prevalence, demand for non-invasive and AI diagnostics, and personalized medicine trends The market presents opportunities driven by rising liver disease prevalence, demand for non-invasive and …
Bioanalytical Testing Services Market Trends and Forecasts Report 2026-2035 Featuring BioAgilytix, Catalent, Charles River, Clean Cells, Coriolis, Eurofins, Genezen, SGS, Solvias, Texcell, Wuxi AppTec
The bioanalytical testing market offers growth opportunities driven by rising demand for personalized medicine, advancements in analytical technologies, and increased outsourcing to CROs to reduce costs and address complex drug development. North America lead…
GLP-1 Agonists Market Outlook Report 2026-2034: New Entrants Face Barriers Due to Consolidation and Patent Protections, Yet Opportunities Lie Within Niche Areas and Emerging Markets
The GLP-1 Agonists Market offers growth opportunities due to rising diabetes cases, innovations in drug delivery, and personalized medicine. Strategic partnerships, especially in the Asia-Pacific, could capitalize on enhanced healthcare access. Challenges inc…
Personalized Cancer Vaccine Market Size to be Worth USD 12.30 Billion by 2035; Increased Adoption of mRNA Vaccine Technology to Boost Industry Growth Globally | SNS Insider
U.S. Personalized Cancer Vaccine Market was valued at USD 76.8 million in 2025 and is expected to reach USD 2.743 billion by 2035 owing to the presence of most prominent personalized vaccine manufacturers U.S. Personalized Cancer Vaccine Market was valued at …
Cancer Vaccine Market Research Report 2026 with Analyst Recommendations - Leveraging AI and Bioinformatics for Precision Development & Fast-Track and Orphan Drug Designations - Global Forecast to 2031
Key opportunities in the cancer vaccine market include growth in preventative and therapeutic vaccines, driven by innovations in immuno-oncology and personalized medicine. The Americas lead due to advanced infrastructure, while Asia Pacific shows rapid growth…
Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight
The personalized medicine market is experiencing strong growth driven by advances in genomics, biomarker-based diagnostics, and targeted therapies. The increasing prevalence of chronic diseases and cancer is accelerating demand for tailored treatment approach…